Lupin gets FDA nod for generic equivalent of Doryx delayed-release tablets
Pharmaceutical giant, Lupin Limited, has achieved a significant milestone by obtaining the US Food and Drug Administration (FDA)’s green light for its Abbreviated New Drug Application (ANDA) of Doxycycline Hyclate Delayed-Release Tablets USP in multiple doses. This nod from the FDA paves the way for Lupin to introduce a generic counterpart of the popular Doryx […]